10 Stocks That Moved From Thursday’s CNBC’s ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Michael Mullette, a former Moderna (NASDAQ:MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit…